EDWARD LEBOVICS
Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology HAWTHORNE, NY NPI 1619089513
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Gastroenterology NY ABBVIE INC. All categories
General Payments — all program years on this page
$35,358.20
- Category: General Payments
- Program years: PY2018–2024
- Record count: 120
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $148.78 across 8 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $148.78 | 8 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $67.43 | 4 |
| Takeda Pharmaceuticals U.S.A., Inc. | $53.13 | 2 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.80 | 1 |
| BOSTON SCIENTIFIC CORPORATION | $13.42 | 1 |
By program year
Records — PY2024 (8)
| Record ID | Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Source |
|---|---|---|---|---|---|---|---|
| 1092279098 | Boston Scientific Corporation | $13.42 | 03/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104148870 | ABBVIE INC. | $19.52 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104148872 | ABBVIE INC. | $17.11 | 09/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104148874 | ABBVIE INC. | $17.11 | 09/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1104148876 | ABBVIE INC. | $13.69 | 11/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137615568 | Takeda Pharmaceuticals U.S.A., Inc. | $28.25 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1137615572 | Takeda Pharmaceuticals U.S.A., Inc. | $24.88 | 07/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
| 1153603299 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | $14.80 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | View at CMS |
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.